Keytruda qlex 4.8ML 1S

Ended Awarded

Contract number
SPE2DR26FBUJN
Awardee
Awarding agency
Obligated
$104,702

Award facts

Contract value 100% obligated
$104,701.74 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $104,701.74 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, on June 8, 2026, for Keytruda (4.8 mL, 1 single-use vial) under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract for pharmaceutical products and medical consumables supporting Department of Defense military healthcare facilities worldwide. Place of performance is Park Ridge, Illinois. The order carries a firm fixed price and an ultimate completion date of June 23, 2026.

Quick answers

Who was awarded contract SPE2DR26FBUJN?

SPE2DR26FBUJN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 8, 2026.

How much is contract SPE2DR26FBUJN worth?

The government has obligated $104,702 on SPE2DR26FBUJN.

Is contract SPE2DR26FBUJN an order under another contract?

Yes. SPE2DR26FBUJN is a delivery order under SPE2DR25D9628, an indefinite delivery contract.

Was contract SPE2DR26FBUJN competed?

The extent of competition for SPE2DR26FBUJN was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award